SCHEMBL3530637

SCHEMBL3530637

Cn1c(C2CC2)c(Br)c(=O)n1-c1cc(Cl)ccc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.48
MAPT P10636 1/20 0.37
NOTUM Q6P988 1/20 0.36
TSHR P16473 3/20 0.36
HTT P42858 2/20 0.36
MAPK1 P28482 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
ADRA1B P35368 3/20 0.35
ALDH1A1 P00352 1/20 0.34
MCOLN3 Q8TDD5 1/20 0.34
HTR1A P08908 2/20 0.34
NR1H4 Q96RI1 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
PMM2 O15305 1/20 0.33
MPI P34949 1/20 0.33
PHOSPHO1 Q8TCT1 1/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3531461 0.85 HSD11B1 (0.55) HSD11B1MAPTNOTUMTSHRHTT
SCHEMBL3532712 0.83 HSD11B1 (0.46) HSD11B1MAPTNOTUMADRA1BALDH1A1
SCHEMBL3535479 0.81 BCHE (0.39) HSD11B1ALDH1A1
SCHEMBL3535108 0.78 DRD2 (0.40) HSD11B1NOTUMALDH1A1HTR1A
SCHEMBL3533829 0.77 L3MBTL1 (0.34) HSD11B1ADRA1BHTR1A
SCHEMBL3531511 0.75 MAPT (0.40) HSD11B1MAPTLMNAHPGDALDH1A1
SCHEMBL3531287 0.75 HSD11B1 (0.38) HSD11B1MAPK1ALDH1A1CNR1CNR2
SCHEMBL3532708 0.74 HSD11B1 (0.39) HSD11B1MAPT
SCHEMBL3533424 0.74 LMNA (0.38) HSD11B1MAPTTSHRLMNAHTR1A
SCHEMBL3528186 0.73 HSD11B1 (0.45) HSD11B1MAPTNOTUMTSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7652057-B2 Pyrazolones as 11b-HSD1 inhibitors for diabetes HOFFMAN-LA ROCHE INC. (US) 2010-01-26 US disclosed
EP-1924562-A2 PYRAZOLONE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-05-28 EP disclosed
WO-2007025880-A2 PYRAZOLONE DERIVATIVES AS 11-BETA HSD1 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2007-03-08 WO disclosed
US-20070049574-A1 New pyrazolones as 11b-HSD1 inhibitors for diabetes F. HOFFMANN-LA ROCHE AG (CH) 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049574-A1 New pyrazolones as 11b-HSD1 inhibitors for diabetes HSD11B1, HSD17B1, HSD17B7 HSD11B1 1/4885MAPT 3706/4885NOTUM 1893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.